← all drugs
Hydromorphone Hydrochloride Injection
in shortage · Analgesia/Addiction · Snapshot: 2026-10-09
Day 3,265
of this shortage, counting from the FDA's first posting on 10/31/2017
- Manufacturers listed
- Fresenius Kabi USA, LLC, Hospira, Inc., a Pfizer Company, Hikma Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc.
- Reported reason(s)
- Demand increase for the drug; Other
- Machine-readable
- JSON for this drug
Presentations (26)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-15) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-6254-01) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 09/18/2026 |
| Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11) | Fresenius Kabi USA, LLC | Unavailable | 09/15/2026 |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03) | Teva Pharmaceuticals USA, Inc. | Available | 10/01/2026 |
| Hydromorphone Hydrochloride, Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01) | Hospira, Inc., a Pfizer Company | Unavailable | 09/22/2026 |
| Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11) | Fresenius Kabi USA, LLC | Unavailable | 10/06/2026 |
| Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06) | Fresenius Kabi USA, LLC | Unavailable | 09/15/2026 |
| Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11) | Fresenius Kabi USA, LLC | Unavailable | 10/06/2026 |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0113-03) | Teva Pharmaceuticals USA, Inc. | Limited Availability | 10/01/2026 |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-3365-10) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-10) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-1283-37) | Hospira, Inc., a Pfizer Company | Unavailable | 09/22/2026 |
| Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-4264-01) | Hospira, Inc., a Pfizer Company | Limited Availability | 09/22/2026 |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 63323-853-25) | Fresenius Kabi USA, LLC | Unavailable | 09/15/2026 |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-1312-36) | Hospira, Inc., a Pfizer Company | Limited Availability | 09/22/2026 |
| Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25) | Fresenius Kabi USA, LLC | Unavailable | 09/15/2026 |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01) | Teva Pharmaceuticals USA, Inc. | Available | 10/01/2026 |
| Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive).
- 2026-09-26 — Hydromorphone Hydrochloride Injection: availability wording revised for 1 presentation(s)
- 2026-09-17 — Hydromorphone Hydrochloride Injection: availability wording revised for 1 presentation(s)
- 2026-09-15 — Hydromorphone Hydrochloride Injection: availability wording revised for 1 presentation(s)
- 2026-09-03 — Hydromorphone Hydrochloride Injection: availability wording revised for 1 presentation(s)
- 2026-08-27 — Hydromorphone Hydrochloride Injection: availability wording revised for 4 presentation(s)
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.